Zhengye Biotechnology (ZYBT) priced its initial public offering of 1.5M shares at a public offering price of $4.00 per share.

AI is merely one facet of a sweeping technological change underway, and companies that fail to recognize the importance of ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show gains.

UNITY Biotechnology (UBX) strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical ...

Vitalik Buterin has sold several meme coins to fund his biotech charity, Kanro, which supports biotechnology research.

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

Swiss medical-aesthetics company Teoxane, which already owns about 6.2% of Revance, on Monday said it has proposed acquiring the rest of the Nashville, Tenn., biotechnology company for $3.60 a share ...

The St. Louis-born biopharmaceutical company has a new life and new focus, four months after its board sought to dissolve the ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

From proton therapy firsts to tumour-killing quantum dots, Tami Freeman shares her pick of this year’s healthcare innovations ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

ANS-014004 is under development for the treatment of solid tumor and non small cell lung cancer (NSCLC). The therapeutic candidate is administered through oral route as tablet formulation. It acts by ...